Sanjive Qazi

Affiliations: 
Biology Gustavus Adolphus College, Saint Peter, MN, United States 
Google:
"Sanjive Qazi"
Mean distance: 15.11 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Uckun FM, Myers DE, Cheng J, et al. (2015) Liposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in Mice. Ebiomedicine. 2: 554-62
Uckun FM, Myers DE, Ma H, et al. (2015) Low Dose Total Body Irradiation Combined With Recombinant CD19-Ligand × Soluble TRAIL Fusion Protein is Highly Effective Against Radiation-Resistant B-Precursor Acute Lymphoblastic Leukemia in Mice. Ebiomedicine. 2: 306-316
Uckun FM, Qazi S, Cheng J. (2015) Targeting leukemic stem cells with multifunctional bioactive polypeptide nanoparticles. Future Oncology (London, England). 11: 1149-52
Uckun FM, Ma H, Cheng J, et al. (2015) CD22ΔE12 as a molecular target for RNAi therapy. British Journal of Haematology. 169: 401-14
Uckun FM, Myers DE, Qazi S, et al. (2015) Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia. The Journal of Clinical Investigation. 125: 1006-18
Uckun FM, Qazi S, Ma H, et al. (2015) CD22ΔE12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule. Integrative Biology : Quantitative Biosciences From Nano to Macro. 7: 237-49
Uckun FM, Mitchell LG, Qazi S, et al. (2015) Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL Ebiomedicine
Uckun FM, Qazi S, Ma H, et al. (2014) A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies. Ebiomedicine. 1: 141-155
Uckun FM, Ma H, Ozer Z, et al. (2014) A PREVIOUSLY UNKNOWN UNIQUE CHALLENGE FOR INHIBITORS OF SYK ATP-BINDING SITE: ROLE OF SYK AS A CELL CYCLE CHECKPOINT REGULATOR. Ebiomedicine. 1: 16-28
Myers DE, Yiv S, Qazi S, et al. (2014) CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells. Integrative Biology : Quantitative Biosciences From Nano to Macro. 6: 766-80
See more...